Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Capranzano

Showing results (221-230 of 224) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 224 results.
The American Journal of Cardiology|April 24, 2022
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry)Carlo A Pivato, Davide Cao, Alessandro Spirito, et al.
The New England Journal of Medicine|August 27, 2021
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNicolas M Van Mieghem, Martin Unverdorben, Christian Hengstenberg, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 12, 2021
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registryJohny Nicolas, Paul Guedeney, Bimmer E Claessen, et al.
Circulation|June 19, 2023
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research ConsortiumDavide Capodanno, Roxana Mehran, Mitchell W Krucoff, et al.
Pageof 23

Showing results (221-230 of 224) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 224 results.
The American Journal of Cardiology|April 24, 2022
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry)Carlo A Pivato, Davide Cao, Alessandro Spirito, et al.
The New England Journal of Medicine|August 27, 2021
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNicolas M Van Mieghem, Martin Unverdorben, Christian Hengstenberg, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 12, 2021
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registryJohny Nicolas, Paul Guedeney, Bimmer E Claessen, et al.
Circulation|June 19, 2023
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research ConsortiumDavide Capodanno, Roxana Mehran, Mitchell W Krucoff, et al.
Pageof 23